Holen Sie sich die Stockscreener-App
1.46
12.57%
-0.21
Handel nachbörslich:
1.48
0.02
+1.37%
Schlusskurs vom Vortag:
$1.67
Offen:
$1.66
24-Stunden-Volumen:
155.49K
Relative Volume:
0.18
Marktkapitalisierung:
$47.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-87.23M
KGV:
-0.4916
EPS:
-2.97
Netto-Cashflow:
$-82.77M
1W Leistung:
+0.00%
1M Leistung:
-4.58%
6M Leistung:
-71.09%
1J Leistung:
-91.07%
1-Tages-Spanne:
$1.46
$1.67
1-Wochen-Bereich:
$1.40
$1.7299
52-Wochen-Spanne:
$0.8801
$19.30
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Vergleichen Sie PEPG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.46 | 47.77M | 0 | -87.23M | -82.77M | -2.97 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
Northern Trust Corp Purchases 7,984 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World
H.C. Wainwright cuts PepGen stock price target to $8, keeps Buy rating - Investing.com Canada
H.C. Wainwright cuts PepGen stock price target to $8, keeps Buy rating By Investing.com - Investing.com South Africa
PepGen price target lowered to $1 from $3 at BofA - Yahoo Finance
PepGen to discontinue DMD programs after PGN-EDO51 did not achieve target - Yahoo Finance
PepGen Inc.’s Strategic Shift to DM1 Program Earns Buy Rating Amid Promising Developments - TipRanks
PepGen (NASDAQ:PEPG) Price Target Lowered to $8.00 at HC Wainwright - Defense World
PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1 - MSN
PepGen (PEPG) Adjusts Focus After Discontinuing DMD Program | PE - GuruFocus
PepGen (PEPG) Shifts Focus from DMD as PGN-EDO51 Results Disappo - GuruFocus
PepGen (PEPG) Price Target Lowered by Analyst HC Wainwright & Co - GuruFocus
PepGen (PEPG) Faces Price Target Cut as Key Program Ends | PEPG Stock News - GuruFocus
PepGen Inc. Receives Buy Rating from Ananda Ghosh Due to Strategic Focus on Promising DM1 Program - TipRanks
PepGen Inc.’s Strategic Shift Amidst DMD Program Discontinuation and Competitive Challenges - TipRanks
PepGen price target lowered to $8 from $14 at H.C. Wainwright - TipRanks
PepGen (PEPG) Adjusts Focus After Discontinuing DMD Program | PEPG Stock News - GuruFocus
PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate - Benzinga
PepGen to discontinue development of experimental Duchenne therapy; shares drop - whbl.com
PepGen Inc. Discontinues DMD Programs After Trial Results - TipRanks
PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update - Business Wire
PepGen appoints new CTO to advance therapies By Investing.com - Investing.com South Africa
PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer - citybiz
PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stoc - GuruFocus
PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stock News - GuruFocus
PepGen appoints new CTO to advance therapies - Investing.com
PepGen Inc. (NASDAQ:PEPG) Holdings Lifted by Dimensional Fund Advisors LP - Defense World
PepGen Inc.’s Promising Advances in DMD and DM1 Programs Justify Buy Rating - TipRanks
PepGen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HC Wainwright Cuts PepGen (NASDAQ:PEPG) Price Target to $14.00 - Defense World
PepGen Inc. Reports Q1 2025 Financial Results - TipRanks
ATTENTION PEPG SHAREHOLDERS: Investors Who Lost Money on PepGen Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
PepGen stock price target cut to $14 from $16 by H.C. Wainwright - Investing.com Nigeria
PepGen (PEPG) Stock Target Price Lowered by HC Wainwright & Co. - GuruFocus
PepGen (PEPG) Price Target Adjusted by H.C. Wainwright Analyst | PEPG Stock News - GuruFocus
PepGen (PEPG) Price Target Adjusted by H.C. Wainwright Analyst | - GuruFocus
PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - BioSpace
PepGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - Bluefield Daily Telegraph
PepGen Inc. CEO Makes Bold Stock Purchase! - TipRanks
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):